# CABOMETYX

NDC: 42388-024
Generic name: cabozantinib
Labeler / Manufacturer: Exelixis, Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: TABLET
Routes: ORAL
Marketing started: 20160425

FDA application: NDA208692

## Active ingredients

- CABOZANTINIB S-MALATE: 20 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"42388-024"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=42388-024
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=3850cce2-6137-42e5-a792-d318c4a4b3b5